Xinxing Ma

1.9k total citations · 1 hit paper
24 papers, 1.5k citations indexed

About

Xinxing Ma is a scholar working on Biomedical Engineering, Materials Chemistry and Oncology. According to data from OpenAlex, Xinxing Ma has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 6 papers in Materials Chemistry and 5 papers in Oncology. Recurrent topics in Xinxing Ma's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (4 papers) and Luminescence and Fluorescent Materials (4 papers). Xinxing Ma is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (4 papers) and Luminescence and Fluorescent Materials (4 papers). Xinxing Ma collaborates with scholars based in China and Singapore. Xinxing Ma's co-authors include Yanguang Li, Zhuang Liu, Liang Cheng, Chao Wang, Kai Yang, Liangzhu Feng, Liang Guo, Huiquan Tao, Xiaoze Shi and Huan Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Functional Materials.

In The Last Decade

Xinxing Ma

23 papers receiving 1.5k citations

Hit Papers

A functionalized graphene oxide-iron oxide nanocomposite ... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxing Ma China 13 1.1k 886 477 255 145 24 1.5k
Cláudia R. Gordijo Canada 15 986 0.9× 634 0.7× 475 1.0× 285 1.1× 154 1.1× 21 1.5k
Zuwu Wei China 22 985 0.9× 671 0.8× 391 0.8× 332 1.3× 179 1.2× 39 1.5k
Miao‐Deng Liu China 20 1.4k 1.2× 662 0.7× 386 0.8× 367 1.4× 254 1.8× 31 1.7k
Meitong Ou China 18 867 0.8× 688 0.8× 287 0.6× 350 1.4× 108 0.7× 24 1.5k
Jingqin Chen China 26 1.6k 1.5× 1.1k 1.2× 333 0.7× 548 2.1× 218 1.5× 43 2.3k
Tianqi Zhang China 18 1.4k 1.3× 1.1k 1.2× 477 1.0× 347 1.4× 181 1.2× 39 1.7k
Yevhen Fatieiev Saudi Arabia 8 680 0.6× 804 0.9× 689 1.4× 313 1.2× 74 0.5× 12 1.5k
Shao‐Kai Sun China 24 1.5k 1.4× 1.3k 1.4× 535 1.1× 466 1.8× 201 1.4× 81 2.5k
Huijun Phoebe Tham Singapore 18 748 0.7× 865 1.0× 321 0.7× 258 1.0× 193 1.3× 19 1.5k

Countries citing papers authored by Xinxing Ma

Since Specialization
Citations

This map shows the geographic impact of Xinxing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxing Ma more than expected).

Fields of papers citing papers by Xinxing Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxing Ma. The network helps show where Xinxing Ma may publish in the future.

Co-authorship network of co-authors of Xinxing Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxing Ma. A scholar is included among the top collaborators of Xinxing Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxing Ma. Xinxing Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Yan, et al.. (2024). Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers. Cancer Immunology Research. 12(11). 1574–1588. 14 indexed citations
4.
Xue, Chen, et al.. (2024). The potential role of breast MRI in evaluation of triple-negative breast cancer and fibroadenoma of less than 3 cm. Translational Cancer Research. 13(8). 4042–4051. 2 indexed citations
5.
Yang, Ling, et al.. (2023). Evaluations of the diagnostic performance of ZOOMit diffusion-weighted imaging and conventional diffusion-weighted imaging for breast lesions. Quantitative Imaging in Medicine and Surgery. 13(12). 8478–8488. 2 indexed citations
7.
Liu, Yan, Hao Yu, Xiang Lv, et al.. (2023). A tetramethylpyrazine releasing hydrogel can potentiate CAR-T cell therapy against triple negative breast cancer by reprogramming tumor vasculatures. Fundamental Research. 5(3). 1288–1297. 5 indexed citations
9.
Ma, Xinxing, Chunjie Wang, Ziliang Dong, Chunhong Hu, & Liangzhu Feng. (2022). Lipid-coated CaCO3-PDA nanoparticles as a versatile nanocarrier to enable pH-responsive dual modal imaging-guided combination cancer therapy. Journal of Materials Chemistry B. 10(21). 4096–4104. 9 indexed citations
10.
Huang, Zhenqi, Hao Lei, Xinxing Ma, et al.. (2021). A Facile Reaction Strategy for the Synthesis of MOF-Based Pine-Needle-Like Nanocluster Hierarchical Structure for Efficient Overall Water Splitting. Inorganic Chemistry. 60(6). 4047–4057. 25 indexed citations
11.
Liu, Yan, Yehui Zhou, Xinxing Ma, & Liming Chen. (2021). Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple‐Negative Breast Cancer Tumor Growth. Advanced Science. 8(4). 16 indexed citations
12.
Liu, Yan, Yehui Zhou, Xinxing Ma, et al.. (2020). The oncogenic role of protein kinase D3 in cancer. Journal of Cancer. 12(3). 735–739. 7 indexed citations
13.
Liu, Yan, Yuzhi Wang, Shiyi Yu, et al.. (2019). The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer. Cellular Physiology and Biochemistry. 52(3). 382–396. 22 indexed citations
14.
Yang, Ling, Mo Zhu, Xinxing Ma, & Chunhong Hu. (2017). USP11 promotes tumorigenesis and enhances MRI detection in breast cancer. Translational Cancer Research. 6(1). 218–227. 1 indexed citations
15.
Yang, Kai, Liang Cheng, Jing Zhu, et al.. (2013). PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: Potential theranostic applications and in vivo toxicity studies. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 1077–1088. 67 indexed citations
16.
Wang, Chao, Liang Cheng, Yumeng Liu, et al.. (2013). Biomedical Applications: Imaging‐Guided pH‐Sensitive Photodynamic Therapy Using Charge Reversible Upconversion Nanoparticles under Near‐Infrared Light (Adv. Funct. Mater. 24/2013). Advanced Functional Materials. 23(24). 3018–3018. 4 indexed citations
17.
Wang, Chao, Liang Cheng, Yumeng Liu, et al.. (2013). Imaging‐Guided pH‐Sensitive Photodynamic Therapy Using Charge Reversible Upconversion Nanoparticles under Near‐Infrared Light. Advanced Functional Materials. 23(24). 3077–3086. 316 indexed citations
18.
Ma, Xinxing, Huiquan Tao, Kai Yang, et al.. (2012). A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Research. 5(3). 199–212. 505 indexed citations breakdown →
19.
Li, Yanguang, Haiyan Hong, Yinyin Chen, et al.. (2011). Synthesis of Pt@Fe2O3 nanorods as MRI probes for in vivo application. Chemical Communications. 47(22). 6320–6320. 20 indexed citations
20.
Xu, Huan, Liang Cheng, Chao Wang, et al.. (2011). Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. Biomaterials. 32(35). 9364–9373. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026